These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6188071)

  • 1. The behavioural effects of intrathecally administered [D-PRO2, D-TRP7,9]-substance P, an analogue with presumed antagonist actions, in the rat.
    Rodriguez RE; Salt TE; Cahusac PM; Hill RG
    Neuropharmacology; 1983 Feb; 22(2):173-6. PubMed ID: 6188071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal (D-Pro2, D-Trp7,9)-SP elicits hypoalgesia and motor blockade in the rat and antagonizes noxious responses induced by substance P.
    Akerman B; Rosell S; Folkers K
    Acta Physiol Scand; 1982 Apr; 114(4):631-3. PubMed ID: 6182754
    [No Abstract]   [Full Text] [Related]  

  • 3. Is substance P a primary afferent neurotransmitter for nociceptive input? IV. 2-Amino-5-phosphonovalerate (APV) and [D-Pro2,D-Trp7,9]-substance P exert different effects on behaviors induced by intrathecal substance P, strychnine and kainic acid.
    Bossut D; Frenk H; Mayer DJ
    Brain Res; 1988 Jul; 455(2):247-53. PubMed ID: 2456842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioural characterization of substance P-induced nociceptive response in mice.
    Takahasi K; Sakurada T; Sakurada S; Kuwahara H; Yonezawa A; Ando R; Kisara K
    Neuropharmacology; 1987 Sep; 26(9):1289-93. PubMed ID: 2444899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural and antinociceptive effects of intrathecally injected substance P analogues in mice.
    Post C; Folkers K
    Eur J Pharmacol; 1985 Jul; 113(3):335-43. PubMed ID: 2412846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do local vasomotor effects elicit the motor deficits induced by intrathecally applied substance P antagonists in the rat?
    Barber A; Wild A; Wedel R
    Neurosci Lett; 1987 Sep; 80(2):219-23. PubMed ID: 2446208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Species differences in the behavioral toxicity produced by intrathecal substance P antagonists: relationship to analgesia.
    Vaught JL; Scott R
    Life Sci; 1987 Jan; 40(2):175-81. PubMed ID: 2432377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioural responses induced by intrathecal injection of 5-hydroxytryptamine in mice are inhibited by a substance P antagonist, D-Pro2, D-Trp7,9-substance P.
    Fasmer OB; Post C
    Neuropharmacology; 1983 Dec; 22(12A):1397-400. PubMed ID: 6198594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.
    Gaumann DM; Grabow TS; Yaksh TL; Casey SJ; Rodriguez M
    Neuroscience; 1990; 39(3):761-74. PubMed ID: 1711172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive and substance P antagonistic effects of intrathecally injected spantide II in rat: no signs of motor impairment or neurotoxicity.
    Wiesenfeld-Hallin Z; Xu XJ; Kristensson K; Håkanson R; Feng DM; Folkers K
    Regul Pept; 1990 Jun; 29(1):1-11. PubMed ID: 1697080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antinociceptive and neurotoxic actions of substance P analogues in the rat's spinal cord after intrathecal administration.
    Post C; Paulsson I
    Neurosci Lett; 1985 Jun; 57(2):159-64. PubMed ID: 2412191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance P analogues containing D-histidine antagonize the behavioural effects of intrathecally co-administered substance P in mice.
    Sakurada T; Yamada T; Sakurada S; Kisara K; Ohba M
    Eur J Pharmacol; 1989 Dec; 174(2-3):153-60. PubMed ID: 2483548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of (D-Pro2, D-Trp7,9)-substance P as an antagonist of substance P responses in the rat central nervous system.
    Salt TE; De Vries GJ; Rodriguez RE; Cahusac PM; Morris R; Hill RG
    Neurosci Lett; 1982 Jun; 30(3):291-5. PubMed ID: 6180363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-Arg1, D-Trp7,9, Leu11-substance P (spantide) does not antagonize substance P-induced hyperexcitability of the nociceptive flexion withdrawal reflex in the rat.
    Wiesenfeld-Hallin Z; Duranti R
    Acta Physiol Scand; 1987 Jan; 129(1):55-9. PubMed ID: 2436439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists.
    Mjellem-Joly N; Lund A; Berge OG; Hole K
    Neurosci Lett; 1991 Nov; 133(1):121-4. PubMed ID: 1724310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice.
    Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K
    Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterisation of NK1 receptor antagonist, [D-Trp7]sendide, on behaviour elicited by substance P in the mouse.
    Sakurada T; Yogo H; Manome Y; Tan-No K; Sakurada S; Yamada A; Kisara K; Ohba M
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Oct; 350(4):387-92. PubMed ID: 7531295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathecal substance P analogue causes motor dysfunction in the rat.
    Matsumura H; Sakurada T; Hara A; Kuwahara H; Ando R; Sakurada S; Kisara K
    Neuropharmacology; 1985 Aug; 24(8):811-3. PubMed ID: 2427968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of intranigral substance P and neurokinin A on striatal dopamine release--I. Interactions with substance P antagonists.
    Reid MS; Herrera-Marschitz M; Hökfelt T; Ohlin M; Valentino KL; Ungerstedt U
    Neuroscience; 1990; 36(3):643-58. PubMed ID: 1700329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of spinal actions of four substance P analogues.
    Couture R; Yashpal K; Henry JL; Escher E; Regoli D
    Eur J Pharmacol; 1985 Mar; 110(1):63-9. PubMed ID: 2408908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.